| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |